General Anesthesia Drugs Market
According to Intent Market Research, the General Anesthesia Drugs Market is expected to grow from USD 6.0 billion in 2023 at a CAGR of 6.7% to touch USD 9.4 billion by 2030. The General Anesthesia Drugs Market is dominated by key players such as, Baxter International Inc., Fresenius Kabi AG, Hospira (Acquired by Pfizer), Gr–nenthal GmbH, and Eli Lilly and Company.